ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,647Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 19

$367K Total Retail Price of All Prescriptions

Rank: 7 out of 19

431 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 431 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 5,726 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 419 360 1 2
SIMVASTATIN 228 208 2 6
HYDROCODONE-ACETAMINOPHEN 228 178 S3 2 1
METFORMIN HCL 224 180 4 5
LISINOPRIL 199 190 5 3
OMEPRAZOLE 197 155 6 4
AMLODIPINE BESYLATE 154 118 7 7
POTASSIUM CHLORIDE 145 139 8 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 101 9 14
FUROSEMIDE 128 128 10 8
PRAVASTATIN SODIUM 119 100 11 43
GABAPENTIN 112 96 12 11
MELOXICAM 112 98 12 25
WARFARIN SODIUM 107 104 14 13
GLYBURIDE 107 73 R 14 62
ATORVASTATIN CALCIUM 95 92 16 17
ATENOLOL 92 79 17 15
FLUOXETINE HCL 88 79 18 46
NAMENDA 85 85 19 68
DONEPEZIL HCL 82 82 20 38
PAROXETINE HCL 76 58 21 51
LANTUS 75 44 22 28
TAMSULOSIN HCL 75 48 22 27
CITALOPRAM HBR 73 73 24 36
LOSARTAN-HYDROCHLOROTHIAZIDE 64 62 25 74
METOPROLOL SUCCINATE 63 60 26 18
ALLOPURINOL 62 56 27 24
CLOPIDOGREL 58 55 28 42
AMLODIPINE BESYLATE-BENAZEPRIL 57 54 29 110
HYDROCHLOROTHIAZIDE 57 57 29 10
AZITHROMYCIN 56 51 31 21
RAMIPRIL 53 53 32 82
METOPROLOL TARTRATE 53 53 32 12
EVISTA 51 43 34 122
SPIRONOLACTONE 51 49 34 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.